Stock·NYSE·Technology
Fabrinet (FN)
- Market cap
- $12.30B
- P/E
- 25.46
- Dividend yield
- None
- Street target
- $739.00median of 9 analysts
- 52-week range
- $305.63 $748.89
FN stock forecast today
Where FN stands today, and what CleaRank Financial AI makes of it.
FN at a glance
Fabrinet (FN): Hold, 58/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($411.06 and $526.41).
- Earnings FN beat estimates in 7 of the 7 reports in our data, yet fell the next day after 6 of those beats.
- Insiders Insiders sold $43.7M and made no open-market purchases over the last 18 months.
- Valuation P/E of 25.5 against 35.1 for the Technology sector: a discount to peers (-27%).
Figures as of October 27, 2026.
CleaRank Financial AI
CleaRank rates Fabrinet (FN) Hold, with a model score of 58/100.
Valuation lifts the score most: the P/E of 25.46 is 27.5% below the sector median (a discount to peers) and the P/S of 2.65 is 65.1% below the sector median. The trend holds it back most: the price is 34.80% below its 200-day average and 16.51% below its 50-day average, and the 50-day average is 21.91% below the 200-day. The 50-day average stands at $411.06 and the 200-day at $526.41. Over the past year the price fell 18.98%.
Only on CleaRank
Figures we compute ourselves from FN's own price, earnings and insider-filing history. Tap one to see it in context.
FN stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $343.21 is 16.5% below the 50-day simple moving average of $411.06.Price above its 200-day average ›
The price is 34.8% below the 200-day simple moving average of $526.41.50-day average above the 200-day ›
The 50-day average ($411.06) is 21.9% below the 200-day average ($526.41), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 8% of its 52-week range, between $305.63 and $748.89.
FN share price
Pick a period: each tab shows how far FN has moved over it, to the last close.
Today's trading
Where FN sits inside today's range and its 52-week range.
FN fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/4P/E below the sector median ›
The trailing P/E of 25.46 is 27.5% below the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 2.65 is 65.1% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $473.0M on revenue of $4.6B, a net margin of 10.2%.Beat estimates in most recent reports ›
FN beat the EPS estimate in 7 of the 7 reports in our data.
Key statistics
The headline figures for FN.
As of October 27, 2026, FN trades at $343.21, with a market value of $12.30B and a P/E ratio of 25.46.
What the numbers say
CleaRank Financial AI's reading of FN's valuation, growth and risks.
Fabrinet (FN) trades at 25.46 times trailing earnings, which places its P/E 27.5% below the Technology median of 35.1. The peer comparison on this page rates that P/E as a discount to peers. With a market capitalisation of $12.3B and trailing earnings of $13.48 a share, FN is valued on figures that are easy to check against the sector.
FN turns sales into profit at a net margin of 10.19% and an operating margin of 10.23%, alongside a return on equity of 21.33%, above the sector median of 13.4%. Rounding out the fundamentals, FN reports debt-to-equity of 0.00.
FN reported results on August 17, 2026 that beat the estimate by 7.61%: $4.10 a share against an expected $3.81. The share price nonetheless dropped 19.38% in the first session after the report.
FN has topped the EPS estimate in all 7 reports in our data, yet the shares still declined in the first session after 6 of those 7 beats. Among the 3 reports before the latest, the biggest reaction followed the August 18, 2025 report, when EPS beat the estimate by 0.76% but the stock fell 12.81%. Analysts expect EPS of $18.23 this fiscal year and $21.94 next, with the current year showing growth of 29.4%.
Normal swings for FN run at about 4.24% a day; measured against the S&P 500, its beta is 1.22. Until the price regains its moving averages, the trend works against holders. The price is 54.17% below its 52-week high of $748.89. Insiders sold $43.7M over the last 18 months and bought none on the open market, though sales of this kind are often planned in advance and say less than purchases would.
FN against the Technology sector
How FN compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: FN trades at a notable discount to sector peers (-27%), which may indicate undervaluation or specific company headwinds.
Return vs XLK: Since May 15, 2025, FN has gained 53.5% against a gain of 61.5% for XLK.
Performance against XLK
FN and the Technology sector fund over the same days.
Revenue and earnings
How much FN sells, and how much of it becomes profit.
The quarterly bars end with Q1 '26 (the quarter to March 31, 2026); FN reported again on August 17, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 18.6% in FY2025 to $3.4B, from $2.9B a year earlier.
Profit margin: The net margin was 9.7% in FY2025, down from 10.3% the year before.
Profitable: FN earned $333M in FY2025.
Earnings reality check
Did FN beat what analysts expected, and how did the stock react?
Earnings record: FN beat the analyst estimate in 7 of the 7 reports in our data.
Market reaction: The stock fell in the first session after 6 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 17, 2026after close | $3.81 | $4.10 | +7.61% | -19.38% | -29.64% |
| May 4, 2026after close | $3.56 | $3.72 | +4.49% | -8.01% | -9.51% |
| Nov 3, 2025after close | $2.82 | $2.92 | +3.55% | +3.75% | +5.47% |
| Aug 18, 2025after close | $2.63 | $2.65 | +0.76% | -12.81% | -4.54% |
| May 5, 2025after close | $2.47 | $2.52 | +2.02% | -7.27% | -2.49% |
| Feb 3, 2025after close | $2.49 | $2.61 | +4.82% | -8.19% | -6.52% |
| Nov 4, 2024after close | $2.38 | $2.39 | +0.42% | -3.91% | +13.07% |
As of October 27, 2026, FN has beaten the analyst EPS estimate in 7 of the 7 reports in our data and fell in the first trading session after 6 of those beats; its latest report, on August 17, 2026, came in 7.61% above the estimate and the stock moved -19.38% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
FN AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 36.7, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 36.7 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of FN
The score, the reasoning behind it, and what could move the price next.
FN is trading in a downtrend. The stock, priced at $343.21, sits 16.51% below its 50-day average of $411.06 and 34.80% below its 200-day average of $526.41. Near the bottom of its 52-week range, the price is 12.30% above the low of $305.63 and 54.17% below the high of $748.89.
The 14-day RSI of 36.7 is in the bearish zone, above the oversold line, and the MACD line is negative. The recent returns are all negative: the price fell 23.68% over the past three months, fell 46.18% over the past six months and fell 18.98% over the past year.
Rating reaffirmed ›
Needham kept its Buy rating on October 27, 2026.
Source: Analyst action, Needham, October 27, 2026
Earnings beat, but the stock fell ›
The August 17, 2026 report beat the EPS estimate by 7.61%, and the share price fell 19.38% in the first session after it.
Source: Earnings report, August 17, 2026
- The two nearest levels to watch are the 20-day EMA at $382.38, just above the price, and the 52-week low at $305.63, just below it.
- A 14-day RSI of 36.7 sits in the bearish zone, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- Following the August 17, 2026 report, the share price dropped 19.38% in the first session. FN has beaten estimates in 7 of the 7 reports in our data.
FN sits below its 50-day and 200-day moving averages ($411.06 and $526.41), and that placement is why the trend reads down. A recovery back above the 50-day would be the first sign of repair. The closest level overhead is the 20-day EMA at $382.38.
The next level below the price is the 52-week low at $305.63. With the RSI in the bearish zone, momentum still leans toward lower prices.
Technical indicators
Momentum and trend for FN, from its daily closes.
As of October 27, 2026, with FN at $343.21, its 14-day RSI is 36.7 (showing bearish momentum without being oversold), its 50-day simple moving average is $411.06 and its 200-day is $526.41.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What FN moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, FN's 1-year correlation of daily returns is +0.50 with S&P 500 (SPY), +0.58 with Nasdaq 100 (QQQ), +0.21 with Bitcoin (BTC) and +0.10 with gold (XAU).
FN price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
7 of 9 analysts rate it a buy or strong buy, 2 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $739.00 is 115.3% above the price.More buy ratings than three months ago ›
7 of 9 rate it a buy now, against 7 of 9 three months ago.
FN Wall Street View
12-month price targets
The price, $343.21, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 27, 2026 | Needham | Maintains | Buy |
| Oct 21, 2026 | Susquehanna | Maintains | Positive |
| Oct 15, 2026 | B. Riley Securities | Maintains | Neutral |
| Aug 20, 2026 | Rosenblatt | Maintains | Buy |
| Aug 18, 2026 | JP Morgan | Maintains | Neutral |
| Aug 18, 2026 | Barclays | Maintains | Overweight |
As of October 27, 2026, 9 Wall Street analysts cover FN: 7 rate it a buy or strong buy, 2 a hold and 0 a sell or strong sell. Their 12-month price targets range from $431.00 to $800.00. The median FN price target is $739.00, 115.3% above the price of $343.21.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
FN trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
FN trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
FN moves about 4.2% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much FN tends to move, against the market and on its own.
FN price history and drawdowns
FN's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 4.24% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 57.8%, from May 2026 to October 2026; the price is still 54.0% below that peak.Most 1-year holds ended higher ›
84% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $90,796, against $42,376 in the S&P 500 (SPY).
FN Drawdowns & Recovery
As of October 27, 2026, FN's worst peak-to-trough fall over the last 10 years with dividends reinvested was -57.8% (May 2026 to October 2026); it is still 54.0% below that peak, and 84% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into FN in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: FN beat the S&P 500 over this period: $90,796 against $42,376.
A $10,000 investment in FN in October 2016 would be worth about $90,796 today with dividends reinvested, compared with about $42,376 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to FN, and which have not.
Strongest month, November: an average of +7.85%, up in 7 of 10 years.
Weakest month, March: an average of -3.15%, up in 3 of 10 years.
This month, October: has averaged +1.26%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, FN's strongest calendar month has been November (average +7.85%, up in 7 of 10 years) and its weakest March (average -3.15%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
FN stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in FN, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in FN today could grow to about $15,111 by 2030 in the base case, with a 90th-percentile outcome near $54,272 and a 10th-percentile outcome around $4,208. Projections are statistical simulations, not guarantees.
FN Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $519 for FN by 2030 in the base case, from $343 today (1.5x over 4 years). The 10th-percentile path ends near $144. These are outcomes of a Monte Carlo simulation run on FN's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $201 | $381 | $721 | |
| 2028 | $171 | $422 | $1,042 | |
| 2029 | $155 | $468 | $1,416 | |
| 2030 | $144 | $519 | $1,863 |
Method: a lognormal simulation of FN's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. FN is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
FN insider trading
What the people running the company have bought and sold.
FN insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought FN shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 27, 2026, FN insiders reported 19 open-market sales worth $43.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Edward T Archer
Officer
|
Sell | 2.5K | $964.8K |
| Aug 20, 2026 | Edward T Archer
Officer
|
Grant | 2.0K | - |
| Aug 20, 2026 | Harpal S. Gill
President
|
Grant | 4.3K | - |
| Aug 20, 2026 | Seamus Grady
Chief Executive Officer
|
Grant | 22.5K | - |
| Aug 20, 2026 | Csaba Sverha
Chief Financial Officer
|
Grant | 2.7K | - |
| Aug 11, 2026 | Edward T Archer
Officer
|
Grant | 6.0K | - |
| Aug 11, 2026 | Harpal S. Gill
President
|
Grant | 12.8K | - |
| Aug 11, 2026 | Seamus Grady
Chief Executive Officer
|
Grant | 20.0K | - |
| Aug 11, 2026 | Csaba Sverha
Chief Financial Officer
|
Grant | 7.6K | - |
| May 22, 2026 | Homa Bahrami
Director
|
Sell | 2.5K | $1.8M |
| Feb 26, 2026 | Thomas F. Kelly
Director
|
Grant | 150 | - |
| Feb 25, 2026 | Thomas F. Kelly
Director
|
Sell | 1.9K | $1.2M |
| Dec 11, 2025 | Forbes I J Alexander
Director
|
Grant | 417 | - |
| Dec 11, 2025 | Homa Bahrami
Director
|
Grant | 417 | - |
| Dec 11, 2025 | Caroline Dowling
Director
|
Grant | 417 | - |
| Dec 11, 2025 | Thomas F. Kelly
Director
|
Grant | 417 | - |
| Dec 11, 2025 | Frank H Levinson
Director
|
Grant | 417 | - |
| Dec 5, 2025 | Darlene Knight
Director
|
Sell | 500 | $241.1K |
| Dec 5, 2025 | Thomas F. Kelly
Director
|
Grant | 25 | - |
| Dec 4, 2025 | Thomas F. Kelly
Director
|
Sell | 2.2K | $1.0M |
| Dec 4, 2025 | Darlene Knight
Director
|
Sell | 500 | $236.0K |
| Dec 3, 2025 | Rollance E. Olson
Director
|
Grant | 70 | - |
| Dec 1, 2025 | Homa Bahrami
Director
|
Sell | 3.5K | $1.6M |
| Nov 26, 2025 | Seamus Grady
Chief Executive Officer
|
Sell | 22.5K | $10.0M |
| Oct 13, 2025 | Caroline Dowling
Director
|
Grant | 93 | - |
| Sep 5, 2025 | Darlene Knight
Director
|
Sell | 479 | $175.3K |
| Sep 5, 2025 | Thomas F. Kelly
Director
|
Grant | 480 | - |
| Sep 4, 2025 | Harpal S. Gill
President
|
Sell | 14.2K | $5.0M |
| Sep 4, 2025 | Edward T Archer
Officer
|
Sell | 3.3K | $1.2M |
| Sep 2, 2025 | Rollance E. Olson
Director
|
Sell | 9.0K | $3.0M |
| Aug 29, 2025 | Edward T Archer
Officer
|
Sell | 3.2K | $1.1M |
| Aug 28, 2025 | Csaba Sverha
Chief Financial Officer
|
Sell | 13.0K | $4.5M |
| Aug 27, 2025 | Seamus Grady
Chief Executive Officer
|
Sell | 9.5K | $3.1M |
| Aug 27, 2025 | Darlene Knight
Director
|
Sell | 1.2K | $402.2K |
| Aug 25, 2025 | Csaba Sverha
Chief Financial Officer
|
Sell | 10.0K | $3.1M |
| Aug 21, 2025 | Edward T Archer
Officer
|
Grant | 3.0K | - |
| Aug 21, 2025 | Harpal S. Gill
President
|
Grant | 6.2K | - |
| Aug 21, 2025 | Seamus Grady
Chief Executive Officer
|
Grant | 11.4K | - |
| Aug 21, 2025 | Csaba Sverha
Chief Financial Officer
|
Grant | 3.8K | - |
| Aug 12, 2025 | Edward T Archer
Officer
|
Grant | 9.4K | - |
| Aug 12, 2025 | Harpal S. Gill
President
|
Grant | 20.5K | - |
| Aug 12, 2025 | Seamus Grady
Chief Executive Officer
|
Grant | 32.7K | - |
| Aug 12, 2025 | Csaba Sverha
Chief Financial Officer
|
Grant | 11.3K | - |
| Jun 4, 2025 | Harpal S. Gill
Chief Executive Officer
|
Sell | 18.7K | $4.5M |
| May 13, 2025 | Rollance E. Olson
Director
|
Sell | 2.5K | $559.9K |
Source: TwelveData, from reported insider filings
FN stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.